Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma
暂无分享，去创建一个
M. Honda | S. Kaneko | Noriho Iida | E. Mizukoshi | T. Yamashita | H. Takatori | Y. Takeda | K. Arai | Y. Sakai | T. Yamashita | K. Kawaguchi | Tetsuro Shimakami | T. Terashima | M. Kitahara | K. Kitamura | H. Kido | Noboru Takata